secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001493152-25-014240
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Insight Molecular Diagnostics raises CEO salary to $520K and CFO to $441K
-------------------------------------------------------------------------

- CEO Joshua Riggs base salary increased from $420,000 to $520,000, effective Sept 15, 2025.
- CFO Andrea James base salary increased from $341,250 to $441,250, effective same date.
- Increases approved by Board and Compensation Committee on September 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225014240/0001493152-25-014240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315225014240/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer